Study S000833

Effects of Liraglutide on Cognition, Chronic Inflammation and Glycemic Control in Overweight and Obese, HIV-infected Subjects With Type 2 Diabetes.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02743598
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: TERMINATED
Enrollment: 4
Start: 2016-09
Primary completion: 2018-06-01
Lead sponsor: Temple University
Conditions: HIV Infection; Diabetes Mellitus Type 2; Obesity; Overweight; Metabolic Syndrome
Interventions: DRUG:Liraglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Neurocognitive performance- change in global cognitive scores on a standard neuropsychological profile [6 months]
Neurocognitive performance- change in domain averages on a standard neuropsychological profile [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.